Centene corporation (CNC)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

836

1,309

1,348

1,268

1,075

894

876

1,061

1,014

808

844

791

708

561

413

359

278

357

351

335

296

264

214

185

175

166

115

67

-10

-11

13

41

108

108

105

100

96

98

0

0

0

Adjustments to reconcile net earnings to net cash provided by operating activities
Depreciation and amortization

776

643

616

593

546

495

451

403

379

361

353

340

329

278

218

169

119

111

106

100

96

89

81

76

71

67

66

65

65

66

65

63

60

58

56

55

53

52

0

0

0

Stock compensation expense

256

177

146

150

150

145

141

140

136

135

135

127

129

148

135

121

106

71

61

58

53

48

44

43

39

37

33

29

27

25

23

21

20

18

16

15

14

13

0

0

0

Impairment

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-35

-44

-37

-10

-10

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain (Loss) on Extinguishment of Debt

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of investments, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6

0

0

0

Gain on sale of UHP

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8

0

0

0

Deferred income taxes

144

55

-101

-143

-136

-129

-179

-46

-27

-108

77

47

58

92

-20

-17

-28

-17

9

-44

-40

-42

-68

-23

-10

-2

6

-12

-18

-14

-17

14

8

2

3

1

8

10

0

0

0

Gain on divestiture

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other adjustments, net

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in assets and liabilities
Premium and trade receivables

2,596

1,076

796

386

1,659

1,173

-3

-93

285

50

-231

-499

-307

-74

906

1,140

200

360

580

643

678

463

327

232

205

143

36

-44

52

117

137

227

136

11

-31

-18

23

23

0

0

0

Other assets

157

234

117

87

69

38

42

209

184

146

-121

-268

-302

-167

0

0

0

-

-

64

13

7

85

15

26

80

32

38

76

37

28

41

20

11

6

8

6

3

0

0

0

Other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-13

-8

15

1

64

36

-2

-3

-3

-2

-0

0

2

1

-0

2

0

0

0

Medical claims liabilities

282

578

1,036

1,166

1,388

1,325

1,333

833

486

359

536

200

307

145

157

358

505

536

527

691

640

609

544

344

250

172

89

220

376

360

483

376

237

149

39

23

16

-30

0

0

0

Unearned revenue

-75

-9

88

-392

-391

-52

-386

-20

16

19

-3

334

427

43

378

25

-40

-27

-29

45

43

129

49

-2

34

3

-89

-6

20

25

78

-76

-110

-109

-0

99

109

25

0

0

0

Accounts payable and accrued expenses

-74

-421

-1,120

-284

-333

-533

-117

-555

447

53

508

153

130

402

-71

-135

16

39

288

512

473

506

530

313

265

152

86

53

16

-22

-9

-3

-48

38

29

6

23

37

0

0

0

Other long-term liabilities

199

185

127

262

128

258

222

152

86

68

-172

257

206

-61

106

370

175

51

173

223

153

89

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other operating activities, net

-23

-25

2

0

16

42

16

15

19

-10

8

7

6

9

39

36

20

5

-36

-26

-11

1

2

-0

-0

3

6

1

-3

-9

-4

1

8

9

4

1

-1

-0

0

0

0

Net cash (used in) provided by operating activities

-73

1,483

1,500

2,147

704

1,234

2,318

1,867

2,087

1,489

2,631

3,016

2,903

1,851

460

40

809

658

827

1,206

1,016

1,223

1,023

713

591

382

183

369

354

279

479

198

135

261

284

320

301

168

0

0

0

Cash flows from investing activities:
Capital expenditures

731

730

716

649

633

675

610

603

557

422

396

393

344

306

260

186

168

150

135

119

112

103

90

79

75

68

57

54

77

82

87

96

71

73

125

122

122

118

0

0

0

Capital expenditures of Centene Center LLC

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Purchases of investments

3,395

2,575

3,229

3,751

3,661

3,846

3,654

2,714

2,839

2,656

2,597

2,793

2,802

2,432

1,772

1,764

1,226

1,321

1,354

1,053

1,155

1,015

861

727

598

790

860

826

798

696

619

622

533

318

433

412

508

615

0

0

0

Sales and maturities of investments

2,328

1,809

1,663

1,989

1,929

1,991

2,129

1,568

1,964

1,862

1,919

1,988

1,706

1,566

1,206

986

761

669

504

461

405

406

447

441

478

579

607

695

653

590

521

400

371

267

298

399

498

570

0

0

0

Proceeds from asset sale

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

13

0

0

0

Acquisitions, net of cash acquired

3,084

36

128

1,850

1,829

2,055

2,008

287

276

50

449

435

515

1,297

850

869

791

18

58

53

68

136

94

90

140

63

0

0

0

-

-

-

-

-

-

-

-

60

0

0

0

Divestiture proceeds, net of divested cash

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other investing activities, net

0

-

-

-

0

-

-

-

-

-

-

0

0

-

-

0

0

-7

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-4,431

-1,532

-2,410

-4,261

-4,194

-4,585

-4,131

-2,023

-1,695

-1,254

-1,523

-1,634

-1,956

-2,469

-1,676

-1,833

-1,424

-813

-1,036

-757

-923

-848

-598

-456

-335

-342

-373

-252

-223

-188

-186

-318

-237

-129

-255

-145

-181

-210

0

0

0

Cash flows from financing activities:
Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7

9

9

9

11

9

8

16

13

13

18

15

14

13

9

3

0

0

0

Proceeds from long-term debt

26,245

24,721

13,053

6,548

5,080

6,077

5,710

5,736

2,855

1,400

3,160

4,045

5,716

8,946

7,576

6,886

5,215

1,925

1,795

1,480

1,730

1,875

1,535

1,295

825

180

0

0

0

-

-

-

-

419

583

595

323

218

0

0

0

Proceeds from stock offering

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

104

0

0

0

Payments of long-term debt

17,915

17,803

12,684

5,965

3,519

4,083

3,921

4,062

2,284

1,353

2,943

3,714

5,248

6,076

4,930

4,228

2,718

1,583

1,466

1,208

1,408

1,674

1,118

975

559

41

81

206

217

218

178

23

264

416

513

513

251

195

0

0

0

Excess tax benefits from stock compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11

5

5

6

6

6

6

11

8

8

8

4

2

2

1

0

0

0

0

Common stock repurchases

598

75

95

95

97

71

64

63

61

65

52

51

54

63

73

73

71

53

32

31

31

29

19

22

20

19

16

12

12

13

8

8

8

7

3

3

3

3

0

0

0

Purchase of noncontrolling interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments for debt extinguishment

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contribution from noncontrolling interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7

9

12

8

5

3

1

1

0

0

0

-

-

-

-

-7

0

0

0

Debt issuance costs

0

-

-

-

0

-

-

-

-

-

-

-

-

76

59

59

51

4

5

5

11

7

6

6

3

4

7

7

4

4

0

0

3

9

0

0

0

-

-

-

0

Other financing activities, net

21

16

23

19

13

9

1

-2

0

5

5

15

16

0

32

10

10

20

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of contingent consideration obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

7,613

6,832

280

470

4,157

4,612

4,381

4,257

441

-82

120

264

391

2,717

2,532

2,536

2,385

305

292

260

303

198

417

313

284

154

134

149

166

179

52

67

43

6

25

34

21

72

0

0

0

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

-3

-2

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease)

3,106

6,781

-626

-1,642

667

1,261

2,567

4,101

833

153

1,227

1,645

1,337

2,098

1,317

743

1,770

150

82

708

395

572

841

570

540

194

-55

266

297

270

344

-52

-59

139

53

208

141

30

0

0

0

Supplemental disclosures of cash flow information:
Interest paid

391

374

323

325

337

323

240

268

238

237

262

228

234

165

140

64

56

55

50

51

40

40

31

30

30

30

26

26

21

22

23

25

27

27

23

21

18

17

0

0

0

Income taxes paid

609

612

619

634

453

448

478

486

495

496

520

539

525

556

493

405

337

328

299

272

240

237

211

173

103

85

49

32

24

43

34

42

61

50

59

66

55

53

0

0

0

Equity issued in connection with acquisitions

11,526

0

0

0

183

507

507

507

324

0

0

0

0

3,105

3,105

3,104

3,104

12

12

71

71

190

189

131

207

75

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above:
Contribution from noncontrolling interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Capital expenditures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0